Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Eur Urol. 2015 Dec 29;70(5):824–828. doi: 10.1016/j.eururo.2015.12.013

Table 3.

Risk of biochemical recurrence of prostate cancer after radical prostatectomy and cumulative number of phosphodiesterase type 5 inhibitor (PDE5i) pills prescribed according to multivariable conditional regression

Cumulative PDE5i pills Odds ratio (95% confidence interval)
Diagnostic variables a RP variables b
None 1.00 (reference) 1.00 (reference)
Below median 0.88 (0.64–1.21) 0.99 (0.71–1.38)
Above median 0.68 (0.48–0.96) 0.73 (0.51–1.04)

RP = radical prostatectomy.

a

Model adjusted for marital status, education, income, prostate-specific antigen, clinical stage, biopsy Gleason grade group, and proportion of positive biopsies.

b

Model adjusted for marital status, education, income, prostate-specific antigen, pathologic stage, prostatectomy Gleason grade group, and surgical margin status.